| Title |
Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent
|
|---|---|
| Published in |
Journal of experimental pharmacology, December 2021
|
| DOI | 10.2147/jep.s330776 |
| Pubmed ID | |
| Authors |
Udaya S Tantry, Karsten Schror, Eliano Pio Navarese, Young-Hoon Jeong, Jacek Kubica, Kevin P Bliden, Paul A Gurbel |
X Demographics
The data shown below were collected from the profiles of 360 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| France | 75 | 21% |
| Netherlands | 6 | 2% |
| Switzerland | 4 | 1% |
| Canada | 4 | 1% |
| Italy | 3 | <1% |
| Belgium | 2 | <1% |
| Spain | 2 | <1% |
| Turkey | 1 | <1% |
| Mauritius | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 261 | 73% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 356 | 99% |
| Practitioners (doctors, other healthcare professionals) | 2 | <1% |
| Scientists | 1 | <1% |
| Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 15 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 2 | 13% |
| Other | 2 | 13% |
| Student > Bachelor | 1 | 7% |
| Student > Master | 1 | 7% |
| Unknown | 9 | 60% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 2 | 13% |
| Biochemistry, Genetics and Molecular Biology | 1 | 7% |
| Neuroscience | 1 | 7% |
| Chemistry | 1 | 7% |
| Engineering | 1 | 7% |
| Other | 0 | 0% |
| Unknown | 9 | 60% |
Attention Score in Context
This research output has an Altmetric Attention Score of 174. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2024.
All research outputs
#237,022
of 25,818,700 outputs
Outputs from Journal of experimental pharmacology
#2
of 154 outputs
Outputs of similar age
#6,601
of 519,804 outputs
Outputs of similar age from Journal of experimental pharmacology
#1
of 4 outputs
Altmetric has tracked 25,818,700 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 154 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 519,804 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them